Zobrazeno 1 - 10
of 278
pro vyhledávání: '"A C, Lankester"'
Autor:
Lotte T. W. Vissers, Monique M. van Ostaijen-ten Dam, Janine E. Melsen, Yanna M. van der Spek, Koen P. Kemna, Arjan C. Lankester, Mirjam van der Burg, Alexander B. Mohseny
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionPediatric patients with unexplained bone marrow failure (BMF) are often categorized as aplastic anemia (AA). Based on the accepted hypothesis of an auto-immune mechanism underlying AA, immune suppressive therapy (IST) might be effective.
Externí odkaz:
https://doaj.org/article/de9be97ece80469b94e05e49065f4ca4
Autor:
Melanie de Gier, Ingrid Pico-Knijnenburg, Monique M. van Ostaijen-ten Dam, Dagmar Berghuis, Frans J. Smiers, Adriaan A. van Beek, Hetty Jolink, Patty M. Jansen, Arjan C. Lankester, Mirjam van der Burg
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for various hematological, immunological and metabolic diseases, replacing the patient’s hematopoietic system with donor-derived healthy hematopoietic stem cells. HSC
Externí odkaz:
https://doaj.org/article/43cc956a59494f48bfa1c4c189550255
Autor:
Lisa V.E. Oostenbrink, Erik G.J. von Asmuth, Cornelia M. Jol-van der Zijde, Anja M. Jansen-Hoogendijk, Carly Vervat, Robbert G.M. Bredius, Maarten J.D. van Tol, Marco W. Schilham, Petr Sedlacek, Marianne Ifversen, Adriana Balduzzi, Peter Bader, Christina Peters, Dirk Jan A.R. Moes, Arjan C. Lankester
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Anti T-lymphocyte globulin (ATLG) is used in hematopoietic stem cell transplantation (HSCT) to prevent graft-versus-host disease (GvHD) and graft failure. To date, insight in ATLG pharmacokinetics and -dynamics (PK/PD) is limited, and population PK (
Externí odkaz:
https://doaj.org/article/ce22bef36d7f40fda15533039f663591
Autor:
Nataël Sorel, Francisco Díaz-Pascual, Boris Bessot, Hanem Sadek, Chloé Mollet, Myriam Chouteau, Marco Zahn, Irene Gil-Farina, Parisa Tajer, Marja van Eggermond, Dagmar Berghuis, Arjan C. Lankester, Isabelle André, Richard Gabriel, Marina Cavazzana, Kasrin Pike-Overzet, Frank J. T. Staal, Chantal Lagresle-Peyrou
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1495 (2024)
Recombinase-activating gene (RAG)-deficient SCID patients lack B and T lymphocytes due to the inability to rearrange immunoglobulin and T cell receptor genes. The two RAG genes act as a required dimer to initiate gene recombination. Gene therapy is a
Externí odkaz:
https://doaj.org/article/4a78380a81614b73972ca4a329e27f1f
Autor:
Joëll E. Bense, Nicole Guilonard, Femke Zwaginga, Anne M. Stiggelbout, Marloes Louwerens, Hilda Mekelenkamp, Arjan C. Lankester, Arwen H. Pieterse, Anne P. J. dePagter
Publikováno v:
Health Expectations, Vol 27, Iss 1, Pp n/a-n/a (2024)
Abstract Introduction The assessment of using patient‐reported outcomes (PROs) within comprehensive care follow‐up programmes, specifically focused on health screening, remains largely unexplored. PROs were implemented in our late effects and com
Externí odkaz:
https://doaj.org/article/92835028ad7947aa8cb92082fbdb5412
Autor:
Joëll E. Bense, Lieke terWelle, Hilda Mekelenkamp, Marieke Schimmel, Marloes Louwerens, Arjan C. Lankester, Arwen H. Pieterse, Anne P. J. dePagter
Publikováno v:
Health Expectations, Vol 25, Iss 5, Pp 2462-2470 (2022)
Abstract Introduction An understanding of the long‐term psychosocial impact of paediatric haematopoietic stem cell transplantation (HSCT) for nonmalignant diseases is needed to optimize pre‐HSCT counselling, supportive care and long‐term follow
Externí odkaz:
https://doaj.org/article/12d6977fa6f34fcdad5be20b9d0b713a
Autor:
Jerold Jeyaratnam, Maura Faraci, Andrew R. Gennery, Katarzyna Drabko, Mattia Algeri, Akira Morimoto, Tiarlan Sirait, Arjan C. Lankester, Michael Albert, Benedicte Neven, Joost Frenkel, on behalf of the EBMT Inborn Errors Working Party
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Objectives Mevalonate kinase deficiency (MKD) is a rare autoinflammatory syndrome. Several reports have described allogeneic hematopoietic stem cell transplantation in severely affected patients, sometimes with promising results. In view of
Externí odkaz:
https://doaj.org/article/390bed8901194b8ebf45ecb4e8ff728a
Autor:
Lisa M. Ott de Bruin, Ingrid Pico-Knijnenburg, Monique M. van Ostaijen-ten Dam, Thomas J. Weitering, Dagmar Berghuis, Robbert G. M. Bredius, Arjan C. Lankester, Mirjam van der Burg
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 21, p 16012 (2023)
In the setting of hematopoietic stem cell transplantation (HSCT), Rituximab (RTX) is used for the treatment and prevention of EBV-associated post-transplantation lymphoproliferative disease or autoimmune phenomena such as autoimmune hemolytic anemia
Externí odkaz:
https://doaj.org/article/951c8bd04861495d8fe1c2a26d695091
Autor:
M. Y. Eileen C. van der Stoep, Dagmar Berghuis, Robbert G. M. Bredius, Emilie P. Buddingh, Alexander B. Mohseny, Frans J. W. Smiers, Henk-Jan Guchelaar, Arjan C. Lankester, Juliette Zwaveling
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Treosulfan is increasingly used as myeloablative agent in conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (HSCT). In our pediatric HSCT program, myalgia was regularly observed after treosulfan-based condition
Externí odkaz:
https://doaj.org/article/32df6957af434a298b3c729660b8644e
Autor:
Janine E. Melsen, Monique M. van Ostaijen-ten Dam, Dorenda J. A. Schoorl, Pieter J. Schol, Daphne A. L. van den Homberg, Arjan C. Lankester, Gertjan Lugthart, Marco W. Schilham
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Human natural killer (NK) cells in lymphoid tissues can be categorized into three subsets: CD56brightCD16+, CD56dimCD16+ and CD69+CXCR6+ lymphoid tissue-resident (lt)NK cells. How the three subsets are functionally and developmentally related is curr
Externí odkaz:
https://doaj.org/article/d24a278f7e624d9c9d9bd5d683bca23e